Author

Lirong Pei

Augusta University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:cell-cell communication· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:imaging· 1 Assay:proteomics· 1

Frequent Co-Authors

Gang ZhouiD· 2 shared Huidong ShiiD· 2 shared Ogacheko D. Okoko· 2 shared Xin Wang· 2 shared Yan Ye· 2 shared Aarav Bhasin· 1 shared Adam B. KeetoniD· 1 shared Ahmad AlimadadiiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Gang ZhouORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

IL13 critically contributes to the antitumor activity of polyfunctional CD4+ T cells driven by constitutively active Stat5

Ogacheko D. Okoko, Mercy Kehinde-Ige, Xin Wang, Yan Ye, Aarav Bhasin, Lirong Pei, Caitlin Brandle, Md Y. Gazi, Zhi-chun Ding, Rafal Pacholczyk, Huidong Shi, Gang Zhou

This study identifies IL13 as a critical cytokine for the antitumor activity of polyfunctional CD4+ T cells modified with constitutively active Stat5, showing its role in enhancing immune responses and tumor control.

bioRxiv · Nov 10, 2026 · PreprintImmunology

Targeting phosphodiesterase 10A disrupts MAPK signaling pathways in the tumor microenvironment to unleash antitumor immunity

Md Yeashin Gazi, Yan Ye, Ogacheko D. Okoko, Xin Wang, Samson Eugin Simon, Ahmad Alimadadi, Nandeeni Suryawanshi, Catlin Brandle, Mei Zheng, Lirong Pei, Khalda Fadlalla, Adam B. Keeton, Yulia Y. Maxuitenko, Xi Chen, Austin W.T. Chiang, , Gang Zhou

This study shows that PDE10A inhibition with ADT-030 suppresses tumor growth by disrupting MAPK signaling and enhancing antitumor immunity through immune cell modulation.

bioRxiv · Feb 28, 2026 · PreprintImmunology